These results indicate that hypermethylation is an important molecular mechanism underlying the inactivation of BRD7 expression and tumour progression in NPC, and targeting BRD7 demethylation can effectively inhibit the malignant progression of NPC, thus offering a potential treatment strategy for NPC patients. This evidence concerns the gene BRD7 and neoplasm.